NIOX Group (LON:NIOX) Insider Sells 16,545 Shares of Stock

NIOX Group Plc (LON:NIOX) insider Garry Watts sold 16,545 shares of the firm’s stock in a transaction on Tuesday, October 27th. The stock was sold at an average price of GBX 80, for a total value of £13,236.

NIOX Group Stock Performance

LON NIOX traded up GBX 0.20 during trading hours on Wednesday, reaching GBX 64.60. The stock had a trading volume of 281,066 shares, compared to its average volume of 902,221. The stock has a fifty day moving average of GBX 67.34 and a 200 day moving average of GBX 63.13. The stock has a market cap of £271.88 million, a P/E ratio of 39.63 and a beta of 0.92. NIOX Group Plc has a 52-week low of GBX 53.84 and a 52-week high of GBX 80. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.94 and a current ratio of 4.60.

NIOX Group (LON:NIOX) last posted its quarterly earnings results on Wednesday, September 30th. The company reported GBX 1.41 earnings per share (EPS) for the quarter. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%. Sell-side analysts predict that NIOX Group Plc will post 1.17 earnings per share for the current year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.